Aflibercept/Nesvacumab | Interleukin Related interleukin-related.com

Product Name :
Aflibercept/Nesvacumab

Search keywords :
Nesvacumab

drugId :
null

Target Vo:
Angiopoietin-2

Target Vo Short Name :
ANGPT2

Moa_Name:
Placental Growth Factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Macular Degeneration

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Estrogen Receptor alpha Antibody (YA768)
Metabotropic glutamate receptor 5 Antibody
GRB2 Antibody: GRB2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts